Search Results 2041-2050 of 18796 for Relapse
Patients must have had histologic verification of one of the malignancies listed below at original diagnosis or at relapse. Ewing sarcoma;; Rhabdomyosarcoma ...
Study treatment should continue until there is documented disease progression, relapse from complete remission (CR), or non-manageable toxicity. A minimum ...
... relapse during maintenance treatment after initial fistula closure) while they were receiving either an immunosuppressive agent or TNF-α antagonist or ...
ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir ...
... relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. Am J Hematol. 2024 Jan; 99 (1):124-134 Epub 2023 Nov 11. View PubMed; Yadav U ...
... relapse, and subsequent therapy. Turkey Tail Mushrooms for women with ER+/HER2- Breast Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to ...
... relapse with standard therapy; A clinical trial investigating adjuvant poly-(ADP-ribose) polymerase inhibition with radiotherapy in inflammatory breast ...
Diagnosis of chemotherapy-resistant lymphoma: a first relapse can occur provided that a second complete remission has occurred. 3. Suspected or diagnosed ...
... relapsed NSCLC. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn ...
... relapse in patients with history of biochemically recurrent prostate cancer and prostate-specific antigen View PubMed; Burkett BJ, Dundar A, Young JR ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.